Medical AI device company AIDOT emphasized the excellence of Cerviray AI, an AI-based remote cervical cancer interpretation system, and the importance of early screening at the Indonesian obstetrics and gynecology academic conference (BCCOG 2023) held recently.

Now in its 5th year, BCCOG invited many prominent speakers in the OB-GYN field and featured in-depth discussions where participants shared presentations and procedural techniques on the latest trends and treatment methods.

At the conference, Ali Budi Harsono, an OB-GYN specialist at Hasan Sadikin Hospital in Indonesia, presented on the importance of early cervical cancer screening using Cerviray under the topic “Cerviray—Applied Innovation for Early Detection of Cervical Cancer.”

In addition, AIDOT’s local partner in Indonesia, PYRIDAM Farma Tak, drew strong interest from attendees by conducting a live product demonstration at its booth exhibition during the conference.

AIDOT said it received 510(k) clearance for Cerviray from the U.S. Food and Drug Administration (FDA) in December of last year, and that it is accelerating preparations for full-scale entry into the U.S. market.

Published: February 23, 2023 / Korea Economic TV / Reporter Yang Jae-jun